1 Watt T, "Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO" 162 : 161-167, 2010
2 Bernardo DC, "Validity and reliability of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 : tagalog among adult filipinos with differentiated thyroid cancer" 33 : 174-180, 2018
3 Gao YJ, "Thyroid tumor-initiating cells : increasing evidence and opportunities for anticancer therapy(review)" 31 : 1035-1042, 2014
4 Massolt ET, "Thyroid hormone and its metabolites in relation to quality of life in patients treated for differentiated thyroid cancer" 85 : 781-788, 2016
5 Megwalu UC, "Thyroid cancer incidence and mortality trends in the United States : 2000-2018" 32 : 560-570, 2022
6 Filetti S, "Thyroid cancer : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up" 30 : 1856-1883, 2019
7 Yin DT, "The association between thyroid cancer and insulin resistance, metabolic syndrome and its components : a systematic review and meta-analysis" 57 : 66-75, 2018
8 이가희, "The Revised 2016 Korean Thyroid Association Guidelines for Thyroid Nodules and Cancers: Differences from the 2015 American Thyroid Association Guidelines" 대한내분비학회 31 (31): 373-378, 2016
9 Shakir MK, "Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma" 18 : 787-792, 2008
10 Lee YK, "South Korean time trade-offvalues for EQ-5D health states : modeling with observed values for 101 health states" 12 : 1187-1193, 2009
1 Watt T, "Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO" 162 : 161-167, 2010
2 Bernardo DC, "Validity and reliability of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 : tagalog among adult filipinos with differentiated thyroid cancer" 33 : 174-180, 2018
3 Gao YJ, "Thyroid tumor-initiating cells : increasing evidence and opportunities for anticancer therapy(review)" 31 : 1035-1042, 2014
4 Massolt ET, "Thyroid hormone and its metabolites in relation to quality of life in patients treated for differentiated thyroid cancer" 85 : 781-788, 2016
5 Megwalu UC, "Thyroid cancer incidence and mortality trends in the United States : 2000-2018" 32 : 560-570, 2022
6 Filetti S, "Thyroid cancer : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up" 30 : 1856-1883, 2019
7 Yin DT, "The association between thyroid cancer and insulin resistance, metabolic syndrome and its components : a systematic review and meta-analysis" 57 : 66-75, 2018
8 이가희, "The Revised 2016 Korean Thyroid Association Guidelines for Thyroid Nodules and Cancers: Differences from the 2015 American Thyroid Association Guidelines" 대한내분비학회 31 (31): 373-378, 2016
9 Shakir MK, "Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma" 18 : 787-792, 2008
10 Lee YK, "South Korean time trade-offvalues for EQ-5D health states : modeling with observed values for 101 health states" 12 : 1187-1193, 2009
11 Dingle IF, "Salivary morbidity and quality of life following radioactive iodine for well-differentiated thyroid cancer" 148 : 746-752, 2013
12 Howlader N, "SEER Cancer Statistics Review, 1975-2018" National Cancer Institute
13 Park J, "Risk factors for cardiovascular disease among thyroid cancer survivors : findings from the Utah Cancer Survivors Study" 103 : 2468-2477, 2018
14 Singer S, "Quality of life in patients with thyroid cancer compared with the general population" 22 : 117-124, 2012
15 Crevenna R, "Quality of life in patients with non-metastatic differentiated thyroid cancer under thyroxine supplementation therapy" 11 : 597-603, 2003
16 Eustatia-Rutten CF, "Quality of life in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial" 64 : 284-291, 2006
17 McIntyre C, "Quality of life in differentiated thyroid cancer" 50 : 133-136, 2018
18 Hoftijzer HC, "Quality of life in cured patients with differentiated thyroid carcinoma" 93 : 200-203, 2008
19 Borget I, "Quality of life and cost-effectiveness assessment of radioiodine ablation strategies in patients with thyroid cancer : results from the Randomized Phase III ESTIMABL Trial" 33 : 2885-2892, 2015
20 Barbus E, "Psychological impact of 131I radioprotection measures on thyroid cancer patients" 91 : 441-447, 2018
21 정규원 ; 원영주 ; 공현주 ; 이은숙, "Prediction of Cancer Incidence and Mortality in Korea, 2019" 대한암학회 51 (51): 431-437, 2019
22 Huang SM, "Postoperative quality of life among patients with thyroid cancer" 47 : 492-499, 2004
23 Jung MS, "Post-treatment cognitive dysfunction in women treated with thyroidectomy for papillary thyroid carcinoma" 25 : 915-923, 2017
24 Kurumety SK, "Post-thyroidectomy neck appearance and impact on quality of life in thyroid cancer survivors" 165 : 1217-1221, 2019
25 Mitchell AL, "Management of thyroid cancer : United Kingdom National Multidisciplinary Guidelines" 130 (130): S150-S160, 2016
26 Valle LA, "In thyroidectomized patients with thyroid cancer, a serum thyrotropin of 30 μU/mL after thyroxine withdrawal is not always adequate for detecting an elevated stimulated serum thyroglobulin" 23 : 185-193, 2013
27 Hirsch D, "Illness perception in patients with differentiated epithelial cell thyroid cancer" 19 : 459-465, 2009
28 Tagay S, "Health-related quality of life, depression and anxiety in thyroid cancer patients" 15 : 695-703, 2006
29 Wang T, "Health-related quality of life of community thyroid cancer survivors in Hangzhou, China" 28 : 1013-1023, 2018
30 Tan LG, "Health-related quality of life in thyroid cancer survivors" 117 : 507-510, 2007
31 Nickel B, "Health-related quality of life after diagnosis and treatment of differentiated thyroid cancer and association with type of surgical treatment" 145 : 231-238, 2019
32 Pickard AS, "Health utilities using the EQ-5D in studies of cancer" 25 : 365-384, 2007
33 Schultz PN, "Health profiles and quality of life of 518 survivors of thyroid cancer" 25 : 349-356, 2003
34 Maki Y, "Fatigue and quality of life among thyroid cancer survivors without persistent or recurrent disease" 11 : e210506-, 2022
35 Lee JC, "Effect of thyroid-stimulating hormone suppression on muscle function after total thyroidectomy in patients with thyroid cancer" 12 : 769074-, 2021
36 Pitoia F, "Dynamic risk assessment in patients with differentiated thyroid cancer" 26 : R553-R566, 2019
37 Bongers PJ, "Differences in long-term quality of life between hemithyroidectomy and total thyroidectomy in patients treated for low-risk differentiated thyroid carcinoma" 167 : 94-101, 2020
38 Husson O, "Development of a disease-specific health-related quality of life questionnaire(THYCA-QoL)for thyroid cancer survivors" 52 : 447-454, 2013
39 Lee JI, "Decreased health-related quality of life in disease-free survivors of differentiated thyroid cancer in Korea" 8 : 101-, 2010
40 Kim MH, "Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases" 14 : 1401-1406, 2005
41 Lee JA, "Comparison of health-related quality of life between cancer survivors treated in designated cancer centers and the general public in Korea" 44 : 141-152, 2014
42 Goswami S, "Clinical factors associated with worse quality-of-life scores in United States thyroid cancer survivors" 166 : 69-74, 2019
43 Miller KD, "Cancer treatment and survivorship statistics, 2016" 66 : 271-289, 2016
44 Blackburn BE, "Aging-related disease risks among young thyroid cancer survivors" 26 : 1695-1704, 2017
45 Lee S, "A prospective comparison of patient body image after robotic thyroidectomy and conventional open thyroidectomy in patients with papillary thyroid carcinoma" 156 : 117-125, 2014
46 Schroeder PR, "A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal" 91 : 878-884, 2006
47 Mozzi A, "A comparison of EuroQol 5-Dimension health-related utilities using Italian, UK, and US preference weights in a patient sample" 8 : 267-274, 2016
48 Giusti M, "A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma" 28 : 599-608, 2005
49 Fugazzola L, "2019 European Thyroid Association guidelines for the treatment and follow-up of advanced radioiodine-refractory thyroid cancer" 8 : 227-245, 2019
50 Haugen BR, "2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer : the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer" 26 : 1-133, 2016